It is now well recognized that plasma LPS-binding protein (LBP) and membrane CD14 present at the surface of cells of the myelo/monocytic lineage are central molecules of the innate immune system, in response to LPS or to bacterial products. This paper reviews the role of LBP and CD14 in models of endotoxemia and infection.
References
1.
Schumann RR, Leong SR, Flaggs GW et al. Structure and function of lipopolysaccharide binding protein . Science1990; 249: 1429—1431.
2.
Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JCCD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science1990; 249: 1431—1433.
3.
Gallay P., Heumann D., Le Roy D., Barras C., Glauser MPLipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock. Proc Natl Acad Sci USA1993; 90: 9935—9938.
4.
Le Roy D., Di Padova F., Tees R. et al. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14. J Immunol1999; 162: 7454—7460.
5.
Jack RS, Fan XL, Bernheiden M. et al. Lipopolysaccharide-binding protein is required to combat a Gram-negative bacterial infection. Nature1997; 389: 742—745.
6.
Wurfel MM, Monks BG, Ingalls RR et al. Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J Exp Med1997; 186: 2051—2056.
7.
Haziot A., Ferrero E., Köntgen F. et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity1996; 4: 407—414.
8.
Schimke J., Mathison J., Morgiewicz J., Ulevitch RJAnti-CD14 mAb treatment provides therapeutic benefit after exposure to endotoxin . Proc Natl Acad Sci USA1998; 95: 13875—13880.
9.
Leturcq D., Moriarty AM, Talbott G., Winn RK, Martin TR, Ulevitch RJAntibodies against CD14 protect primates from endotoxin-induced shock. J Clin Invest1996; 98: 1533—1538.
10.
Adachi Y., Satokawa C., Saeki M. et al. Inhibition by a CD14 monoclonal antibody of lipopolysaccharide binding to murine macrophages. J Endotoxin Res1999; 5: 139—146.
11.
Wenneras C. , Ave P., Huerre M. et al. Blockade of CD14 increases Shigella-mediated invasion and tissue destruction. J Immunol2000; 164: 3214—3221.
12.
Le Roy D., Di Padoba F., Adachi Y., Glauser MP, Calandra T., Heumann D.Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against Gram-negative bacteria. J Immunol2001; 167: 2759—2765.
